-
Ƶ and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis Cambridge, UK, 7 May 2024: Ƶ (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has entered a research collaboration with…
-
Ƶ appoints Gavin Burns as Vice President of Quality and Operations
Cambridge, UK, 22 November 2023: Ƶ (“Broken String”), a genomics company that has built a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the appointment of Gavin Burns, PhD, as Vice President of Quality and Operations. With an extensive background leading quality assurance in…
-
Ƶ’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing
Cambridge, UK, 18 October 2023: Ƶ (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that its INDUCE-seq™ DNA break-mapping technology had been used in a peer-reviewed research paper to characterize off-target effects of CRISPR-Cas9 gene editing…
-
Ƶ strengthens senior leadership team to accelerate product development
Cambridge, UK, 02 October 2023: Ƶ (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the expansion of its senior leadership team with the appointment of Vincent Smith, PhD, as Chief Technology Officer. Bringing significant expertise in his…
-
Ƶ Closes $15M Series A Funding Round
Cambridge, UK, 18 September 2023: Ƶ (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from…